ID   FGD4_HUMAN              Reviewed;         766 AA.
AC   Q96M96; Q6ULS2; Q8TCP6;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 2.
DT   28-JUN-2023, entry version 178.
DE   RecName: Full=FYVE, RhoGEF and PH domain-containing protein 4;
DE   AltName: Full=Actin filament-binding protein frabin;
DE   AltName: Full=FGD1-related F-actin-binding protein;
DE   AltName: Full=Zinc finger FYVE domain-containing protein 6;
GN   Name=FGD4; Synonyms=FRABP, ZFYVE6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RA   Lu L., Huang X.Y., Xu M., Yin L.L., Li J.M., Zhou Z.M., Sha J.H.;
RT   "Cloning a new transcript of actin-filament binding protein frabin in
RT   testis.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   FUNCTION.
RX   PubMed=15133042; DOI=10.1074/jbc.m401592200;
RA   Chen X.M., Splinter P.L., Tietz P.S., Huang B.Q., Billadeau D.D.,
RA   LaRusso N.F.;
RT   "Phosphatidylinositol 3-kinase and frabin mediate Cryptosporidium parvum
RT   cellular invasion via activation of Cdc42.";
RL   J. Biol. Chem. 279:31671-31678(2004).
RN   [5]
RP   INVOLVEMENT IN CMT4H, VARIANTS CMT4H ARG-298 AND THR-298, TISSUE
RP   SPECIFICITY, AND ALTERNATIVE SPLICING.
RX   PubMed=17564959; DOI=10.1086/518428;
RA   Delague V., Jacquier A., Hamadouche T., Poitelon Y., Baudot C.,
RA   Boccaccio I., Chouery E., Chaouch M., Kassouri N., Jabbour R., Grid D.,
RA   Megarbane A., Haase G., Levy N.;
RT   "Mutations in FGD4 encoding the Rho GDP/GTP exchange factor FRABIN cause
RT   autosomal recessive Charcot-Marie-Tooth type 4H.";
RL   Am. J. Hum. Genet. 81:1-16(2007).
RN   [6]
RP   INVOLVEMENT IN CMT4H, AND VARIANT CMT4H ARG-298.
RX   PubMed=17564972; DOI=10.1086/518770;
RA   Stendel C., Roos A., Deconinck T., Pereira J., Castagner F., Niemann A.,
RA   Kirschner J., Korinthenberg R., Ketelsen U.-P., Battaloglu E., Parman Y.,
RA   Nicholson G., Ouvrier R., Seeger J., De Jonghe P., Weis J., Kruettgen A.,
RA   Rudnik-Schoeneborn S., Bergmann C., Suter U., Zerres K., Timmerman V.,
RA   Relvas J.B., Senderek J.;
RT   "Peripheral nerve demyelination caused by a mutant Rho GTPase guanine
RT   nucleotide exchange factor, frabin/FGD4.";
RL   Am. J. Hum. Genet. 81:158-164(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-702, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Activates CDC42, a member of the Ras-like family of Rho- and
CC       Rac proteins, by exchanging bound GDP for free GTP. Plays a role in
CC       regulating the actin cytoskeleton and cell shape. Activates MAPK8 (By
CC       similarity). {ECO:0000250, ECO:0000269|PubMed:15133042}.
CC   -!- SUBUNIT: Homooligomer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Cell
CC       projection, filopodium {ECO:0000250}. Note=Concentrated in filopodia
CC       and poorly detected at lamellipodia. Binds along the sides of actin
CC       fibers (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q96M96-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96M96-2; Sequence=VSP_013078, VSP_013082;
CC       Name=3;
CC         IsoId=Q96M96-3; Sequence=VSP_013079, VSP_013080, VSP_013081;
CC   -!- TISSUE SPECIFICITY: Expressed in different tissues, including brain,
CC       cerebellum, peripheral nerve, skeletal muscle, heart, uterus, placenta
CC       and testis. {ECO:0000269|PubMed:17564959}.
CC   -!- DOMAIN: The part of the protein spanning the actin filament-binding
CC       domain together with the DH domain and the first PH domain is necessary
CC       and sufficient for microspike formation. Activation of MAPK8 requires
CC       the presence of all domains with the exception of the actin filament-
CC       binding domain (By similarity). {ECO:0000250}.
CC   -!- DISEASE: Charcot-Marie-Tooth disease 4H (CMT4H) [MIM:609311]: A
CC       recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder
CC       of the peripheral nervous system, characterized by progressive weakness
CC       and atrophy, initially of the peroneal muscles and later of the distal
CC       muscles of the arms. Charcot-Marie-Tooth disease is classified in two
CC       main groups on the basis of electrophysiologic properties and
CC       histopathology: primary peripheral demyelinating neuropathies
CC       (designated CMT1 when they are dominantly inherited) and primary
CC       peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are
CC       characterized by severely reduced nerve conduction velocities (less
CC       than 38 m/sec), segmental demyelination and remyelination with onion
CC       bulb formations on nerve biopsy, slowly progressive distal muscle
CC       atrophy and weakness, absent deep tendon reflexes, and hollow feet. By
CC       convention autosomal recessive forms of demyelinating Charcot-Marie-
CC       Tooth disease are designated CMT4. {ECO:0000269|PubMed:17564959,
CC       ECO:0000269|PubMed:17564972}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY367054; AAQ72372.1; -; mRNA.
DR   EMBL; AK057294; BAB71413.1; -; mRNA.
DR   EMBL; AL713762; CAD28532.1; -; mRNA.
DR   CCDS; CCDS8727.1; -. [Q96M96-1]
DR   RefSeq; NP_001291409.1; NM_001304480.1.
DR   RefSeq; NP_001317302.1; NM_001330373.1.
DR   RefSeq; NP_001317303.1; NM_001330374.1.
DR   RefSeq; NP_640334.2; NM_139241.3. [Q96M96-1]
DR   RefSeq; XP_011518857.1; XM_011520555.1.
DR   RefSeq; XP_011518858.1; XM_011520556.1.
DR   AlphaFoldDB; Q96M96; -.
DR   SMR; Q96M96; -.
DR   BioGRID; 125734; 22.
DR   IntAct; Q96M96; 6.
DR   STRING; 9606.ENSP00000394487; -.
DR   iPTMnet; Q96M96; -.
DR   PhosphoSitePlus; Q96M96; -.
DR   BioMuta; FGD4; -.
DR   DMDM; 116241363; -.
DR   EPD; Q96M96; -.
DR   jPOST; Q96M96; -.
DR   MassIVE; Q96M96; -.
DR   MaxQB; Q96M96; -.
DR   PaxDb; Q96M96; -.
DR   PeptideAtlas; Q96M96; -.
DR   ProteomicsDB; 77320; -. [Q96M96-1]
DR   ProteomicsDB; 77321; -. [Q96M96-2]
DR   ProteomicsDB; 77322; -. [Q96M96-3]
DR   Antibodypedia; 48934; 123 antibodies from 20 providers.
DR   DNASU; 121512; -.
DR   Ensembl; ENST00000427716.7; ENSP00000394487.2; ENSG00000139132.16. [Q96M96-1]
DR   Ensembl; ENST00000525053.6; ENSP00000433666.2; ENSG00000139132.16. [Q96M96-1]
DR   Ensembl; ENST00000583694.2; ENSP00000462623.2; ENSG00000139132.16. [Q96M96-1]
DR   GeneID; 121512; -.
DR   KEGG; hsa:121512; -.
DR   UCSC; uc001rkz.5; human. [Q96M96-1]
DR   AGR; HGNC:19125; -.
DR   CTD; 121512; -.
DR   DisGeNET; 121512; -.
DR   GeneCards; FGD4; -.
DR   HGNC; HGNC:19125; FGD4.
DR   HPA; ENSG00000139132; Low tissue specificity.
DR   MalaCards; FGD4; -.
DR   MIM; 609311; phenotype.
DR   MIM; 611104; gene.
DR   neXtProt; NX_Q96M96; -.
DR   OpenTargets; ENSG00000139132; -.
DR   Orphanet; 99954; Charcot-Marie-Tooth disease type 4H.
DR   PharmGKB; PA134907925; -.
DR   VEuPathDB; HostDB:ENSG00000139132; -.
DR   eggNOG; KOG4424; Eukaryota.
DR   GeneTree; ENSGT00940000155765; -.
DR   InParanoid; Q96M96; -.
DR   OMA; EREHSFY; -.
DR   OrthoDB; 5385125at2759; -.
DR   PhylomeDB; Q96M96; -.
DR   TreeFam; TF316247; -.
DR   PathwayCommons; Q96M96; -.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   Reactome; R-HSA-9013148; CDC42 GTPase cycle.
DR   SignaLink; Q96M96; -.
DR   SIGNOR; Q96M96; -.
DR   BioGRID-ORCS; 121512; 6 hits in 1139 CRISPR screens.
DR   ChiTaRS; FGD4; human.
DR   GeneWiki; FGD4; -.
DR   GenomeRNAi; 121512; -.
DR   Pharos; Q96M96; Tbio.
DR   PRO; PR:Q96M96; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q96M96; protein.
DR   Bgee; ENSG00000139132; Expressed in jejunal mucosa and 188 other tissues.
DR   ExpressionAtlas; Q96M96; baseline and differential.
DR   Genevisible; Q96M96; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030175; C:filopodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0001726; C:ruffle; ISS:UniProtKB.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031267; F:small GTPase binding; ISS:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0007010; P:cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0046847; P:filopodium assembly; ISS:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; ISS:UniProtKB.
DR   GO; GO:0043087; P:regulation of GTPase activity; ISS:UniProtKB.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   CDD; cd15741; FYVE_FGD1_2_4; 1.
DR   CDD; cd15791; PH1_FDG4; 1.
DR   CDD; cd13236; PH2_FGD1-4; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; Dbl homology (DH) domain; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 2.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR037742; FDG4_N_PH.
DR   InterPro; IPR035941; FGD1-4_PH2.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000306; Znf_FYVE.
DR   InterPro; IPR017455; Znf_FYVE-rel.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR12673; FACIOGENITAL DYSPLASIA PROTEIN; 1.
DR   PANTHER; PTHR12673:SF98; FYVE, RHOGEF AND PH DOMAIN-CONTAINING PROTEIN 4; 1.
DR   Pfam; PF01363; FYVE; 1.
DR   Pfam; PF00169; PH; 2.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00064; FYVE; 1.
DR   SMART; SM00233; PH; 2.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; DBL homology domain (DH-domain); 1.
DR   SUPFAM; SSF50729; PH domain-like; 2.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 2.
DR   PROSITE; PS50178; ZF_FYVE; 1.
PE   1: Evidence at protein level;
KW   Actin-binding; Alternative splicing; Cell projection;
KW   Charcot-Marie-Tooth disease; Cytoplasm; Cytoskeleton; Disease variant;
KW   Guanine-nucleotide releasing factor; Metal-binding; Neurodegeneration;
KW   Neuropathy; Phosphoprotein; Reference proteome; Repeat; Zinc; Zinc-finger.
FT   CHAIN           1..766
FT                   /note="FYVE, RhoGEF and PH domain-containing protein 4"
FT                   /id="PRO_0000080947"
FT   DOMAIN          206..393
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          422..521
FT                   /note="PH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          643..740
FT                   /note="PH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   ZN_FING         559..619
FT                   /note="FYVE-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   REGION          1..150
FT                   /note="Actin filament-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          46..83
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          134..188
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          742..766
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        53..83
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        136..157
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        170..188
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        752..766
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         565
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         568
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         582
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         585
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         590
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         593
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         611
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         614
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   MOD_RES         702
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         716
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZT5"
FT   VAR_SEQ         1..248
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_013078"
FT   VAR_SEQ         1..30
FT                   /note="MEEIKPASASCVSKEKPSKVSDLISRFEGG -> MFSCFLCILSF (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_013079"
FT   VAR_SEQ         201..207
FT                   /note="ETNEQKL -> VEHETSS (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_013080"
FT   VAR_SEQ         208..766
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_013081"
FT   VAR_SEQ         515..766
FT                   /note="ALQETIDAFHQRHETFRNAIAKDNDIHSEVSTAELGKRAPRWIRDNEVTMCM
FT                   KCKEPFNALTRRRHHCRACGYVVCWKCSDYKAQLEYDGGKLSKVCKDCYQIISGFTDSE
FT                   EKKRKGILEIESAEVSGNSVVCSFLQYMEKSKPWQKAWCVIPKQDPLVLYMYGAPQDVR
FT                   AQATIPLLGYVVDEMPRSADLPHSFKLTQSKSVHSFAADSEELKQKWLKVILLAVTGET
FT                   PGGPNEHPATLDDHPEPKKKSEC -> RRGFAMLPRLISNS (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_013082"
FT   VARIANT         298
FT                   /note="M -> R (in CMT4H; found in patient's fibroblasts but
FT                   absent from peripheral nerve where splicing defects and
FT                   aberrant transcripts are detected; dbSNP:rs63749871)"
FT                   /evidence="ECO:0000269|PubMed:17564959,
FT                   ECO:0000269|PubMed:17564972"
FT                   /id="VAR_034957"
FT   VARIANT         298
FT                   /note="M -> T (in CMT4H; dbSNP:rs63749871)"
FT                   /evidence="ECO:0000269|PubMed:17564959"
FT                   /id="VAR_044321"
FT   CONFLICT        79
FT                   /note="T -> A (in Ref. 2; BAB71413)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        303
FT                   /note="V -> A (in Ref. 1; AAQ72372)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   766 AA;  86626 MW;  B919A7C1D164B05D CRC64;
     MEEIKPASAS CVSKEKPSKV SDLISRFEGG SSLSNYSDLK KESAVNLNAP RTPGRHGLTT
     TPQQKLLSQH LPQRQGNDTD KTQGAQTCVA NGVMAAQNQM ECEEEKAATL SSDTSIQASE
     PLLDTHIVNG ERDETATAPA SPTTDSCDGN ASDSSYRTPG IGPVLPLEER GAETETKVQE
     RENGESPLEL EQLDQHHEMK ETNEQKLHKI ANELLLTERA YVNRLDLLDQ VFYCKLLEEA
     NRGSFPAEMV NKIFSNISSI NAFHSKFLLP ELEKRMQEWE TTPRIGDILQ KLAPFLKMYG
     EYVKGFDNAM ELVKNMTERI PQFKSVVEEI QKQKICGSLT LQHHMLEPVQ RIPRYEMLLK
     DYLRKLPPDS LDWNDAKKSL EIISTAASHS NSAIRKMENL KKLLEIYEML GEEEDIVNPS
     NELIKEGQIL KLAARNTSAQ ERYLFLFNNM LLYCVPKFSL VGSKFTVRTR VGIDGMKIVE
     TQNEEYPHTF QVSGKERTLE LQASSAQDKE EWIKALQETI DAFHQRHETF RNAIAKDNDI
     HSEVSTAELG KRAPRWIRDN EVTMCMKCKE PFNALTRRRH HCRACGYVVC WKCSDYKAQL
     EYDGGKLSKV CKDCYQIISG FTDSEEKKRK GILEIESAEV SGNSVVCSFL QYMEKSKPWQ
     KAWCVIPKQD PLVLYMYGAP QDVRAQATIP LLGYVVDEMP RSADLPHSFK LTQSKSVHSF
     AADSEELKQK WLKVILLAVT GETPGGPNEH PATLDDHPEP KKKSEC
//
